Article

Study: Not all topography devices are alike

Subclinical haze after CXL can affect corneal topography measurements; a comparison shows that measurements with four different devices cannot be used interchangeably.

Take-home message: Subclinical haze after CXL can affect corneal topography measurements; a comparison shows that measurements with four different devices cannot be used interchangeably.

 

 

By Vanessa Caceres; Reviewed by Aarti Agrawal, MD

Bangalore, India-Devices used to measure corneal topography after collagen crosslinking (CXL) should not be used interchangeably, said Aarti Agrawal, MD.

In a study, it was found that four commonly used devices had variable measurement results, and that subclinical corneal haze can affect measurements obtained with commonly used topography devices, said Dr. Agrawal, Narayana Nethralaya, Bangalore, India.

Dr. Agrawal and fellow researchers included 60 eyes from 60 patients with keratoconus who had undergone accelerated CXL a year before. All eyes were measured with three Scheimpflug-based devices and one slit-scanning imaging device. The devices used were the Orbscan II (slit-scanning beam), Galilei G6 (Placido disk with dual Scheimpflug), Sirius (single Scheimpflug with Placido), and Pentacam HR (single Scheimpflug).

Each eye followed a standard methodology-it was aligned to the visual axis by the central fixation light, and a single operator captured three measurements from each eye from all machines. Measurements captured were thinnest corneal thickness as well as steep (K1) and flat (K2) keratometry and astigmatism.

Patients with previous lamellar surgery, corneal scarring, penetrating keratoplasty, and corneal ring implantation were excluded from the study.

 

Researchers found that the thinnest corneal thickness was most variable with the Orbscan as compared with other devices.  The within-subject standard deviation and coefficient of repeatability with Orbscan showed the highest variability for all the corneal parameters in comparison with other devices.

Among the Scheimflug, Galilei was found to be the most repeatable and in agreement for the various corneal parameters, followed by Sirius and Pentacam, Dr. Agrawal said.

One clinical implication to keep in mind is that post-CXL, the cornea behaves differently, and the interpretation of topography should be done with caution, Dr. Agrawal said.

“There can be subclinical haze which might not be evident on slit lamp examination,” Dr. Agrawal noted.

 Corneal haze was quantified using the densitometry software in Pentacam HR.

Dr. Agrawal and fellow researchers are working on a correction factor that can be applied in each of the device in presence of haze.

 

Aarti Agrawal, MD

E: aartiagrawal1988@gmail.com

This article was adapted from Dr. Agrawal’s presentation at the 2016 meeting of the American Society of Cataract and Refractive Surgery. Dr. Agrawal did not indicate any financial interest in the subject matter.

 

 

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.